| Basics |
Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments.
|
| IPO Date: |
January 2, 1990 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$373.35B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.68 | 0.64%
|
| Avg Daily Range (30 D): |
$1.11 | 0.71%
|
| Avg Daily Range (90 D): |
$1.33 | 0.86%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
7.99M |
| Avg Daily Volume (30 D): |
6.2M |
| Avg Daily Volume (90 D): |
6.55M |
| Trade Size |
| Avg Trade Size (Sh.): |
142 |
| Avg Trade Size (Sh.) (30 D): |
57 |
| Avg Trade Size (Sh.) (90 D): |
58 |
| Institutional Trades |
| Total Inst.Trades: |
151,978 |
| Avg Inst. Trade: |
$8.09M |
| Avg Inst. Trade (30 D): |
$23.13M |
| Avg Inst. Trade (90 D): |
$23.05M |
| Avg Inst. Trade Volume: |
.08M |
| Avg Inst. Trades (Per Day): |
27 |
| Market Closing Trades |
| Avg Closing Trade: |
$127.4M |
| Avg Closing Trade (30 D): |
$259.35M |
| Avg Closing Trade (90 D): |
$264M |
| Avg Closing Volume: |
984.32K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$9.06
|
$4.57
|
$1.42
|
|
Diluted EPS
|
$8.99
|
$4.54
|
$1.41
|
|
Revenue
|
$ 89.33B
|
$ 21.89B
|
$ 22.52B
|
|
Gross Profit
|
$ 61.01B
|
$ 14.54B
|
$ 15.39B
|
|
Net Income / Loss
|
$ 21.81B
|
$ 11B
|
$ 3.43B
|
|
Operating Income / Loss
|
$ 26.6B
|
$ 13.63B
|
$ 3.89B
|
|
Cost of Revenue
|
$ 28.32B
|
$ 7.36B
|
$ 7.13B
|
|
Net Cash Flow
|
$ 13B
|
$ 14.37B
|
$ 4.13B
|
|
PE Ratio
|
0.00
|
|
|
|
|
|
